US20030003537A1 - Method and composition of matter for enhancing staining of microorganisms - Google Patents
Method and composition of matter for enhancing staining of microorganisms Download PDFInfo
- Publication number
- US20030003537A1 US20030003537A1 US10/134,575 US13457502A US2003003537A1 US 20030003537 A1 US20030003537 A1 US 20030003537A1 US 13457502 A US13457502 A US 13457502A US 2003003537 A1 US2003003537 A1 US 2003003537A1
- Authority
- US
- United States
- Prior art keywords
- composition
- tissue
- staining
- matter
- stain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims abstract description 15
- 239000000203 mixture Substances 0.000 title claims abstract description 13
- 238000010186 staining Methods 0.000 title claims abstract description 13
- 244000005700 microbiome Species 0.000 title claims abstract description 12
- 230000002708 enhancing effect Effects 0.000 title claims abstract description 5
- PBTFWNIEMRWXLI-UHFFFAOYSA-L alcian yellow Chemical compound [Cl-].[Cl-].CN(C)C(=[N+](C)C)SCC1=C(C)C=C2SC(C3=CC=C(C=C3)N=NC3=CC=C(C=C3)C3=NC=4C=C(C(=CC=4S3)C)CSC(N(C)C)=[N+](C)C)=NC2=C1 PBTFWNIEMRWXLI-UHFFFAOYSA-L 0.000 claims abstract description 18
- 239000003833 bile salt Substances 0.000 claims abstract description 7
- FHHPUSMSKHSNKW-SMOYURAASA-M sodium deoxycholate Chemical group [Na+].C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 FHHPUSMSKHSNKW-SMOYURAASA-M 0.000 claims description 7
- CDMADVZSLOHIFP-UHFFFAOYSA-N disodium;3,7-dioxido-2,4,6,8,9-pentaoxa-1,3,5,7-tetraborabicyclo[3.3.1]nonane;decahydrate Chemical group O.O.O.O.O.O.O.O.O.O.[Na+].[Na+].O1B([O-])OB2OB([O-])OB1O2 CDMADVZSLOHIFP-UHFFFAOYSA-N 0.000 claims description 2
- 206010061459 Gastrointestinal ulcer Diseases 0.000 abstract description 3
- 229950003937 tolonium Drugs 0.000 description 8
- HNONEKILPDHFOL-UHFFFAOYSA-M tolonium chloride Chemical compound [Cl-].C1=C(C)C(N)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 HNONEKILPDHFOL-UHFFFAOYSA-M 0.000 description 8
- 239000000243 solution Substances 0.000 description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 230000000694 effects Effects 0.000 description 3
- 229920001213 Polysorbate 20 Polymers 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000001574 biopsy Methods 0.000 description 2
- 239000001045 blue dye Substances 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000003599 detergent Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 230000002962 histologic effect Effects 0.000 description 2
- 238000007901 in situ hybridization Methods 0.000 description 2
- 239000007800 oxidant agent Substances 0.000 description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
- 238000007447 staining method Methods 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 150000004992 toluidines Chemical class 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 239000003298 DNA probe Substances 0.000 description 1
- 108020004518 RNA Probes Proteins 0.000 description 1
- 239000003391 RNA probe Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000002055 immunohistochemical effect Effects 0.000 description 1
- 238000003364 immunohistochemistry Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- BSVBQGMMJUBVOD-UHFFFAOYSA-N trisodium borate Chemical compound [Na+].[Na+].[Na+].[O-]B([O-])[O-] BSVBQGMMJUBVOD-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/30—Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/30—Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
- G01N2001/302—Stain compositions
Definitions
- This invention is in the general field of histology, in particular the invention is an improved composition and method for staining microorganisms.
- Histology is the practice of examination and classification of tissue to aid in diagnosis of a disease or condition expressed in the morphology of the affected tissue.
- the practice of staining tissue or features of tissues with a visualizing agent to visualize or detect them, and thus provide a scientific basis for diagnosing a patient, is a very old art, going back over one hundred years. Histology can be divided into three basic practice areas: immunohistochemistry (use of antibodies to visualize tissue structures), in situ hybridization (use of DNA/RNA probes to detect) or special stains (chemical staining of tissue).
- Special stains is the term given to a collection of chemically-based stains that have been developed in response to difficult to stain tissue types, unusual diseases, infectious diseases or other non-typical situations affecting the tissue.
- the invention is directed to a method and composition of matter for enhancing the staining of tissue or features of interest therein by applying an effective amount of a bile salt in combination with a special stain to a tissue suspected of harboring a microorganism or other feature of diagnostic interest.
- the particular invention herein is directed to detecting H. pylori, the microorganism responsible for gastrointestinal ulcers.
- composition of matter is a sensitizer for Alcian Yellow stain.
- FIG. 1 includes two color pictures of a section of tissue on a slide stained using the recipe and Alcian Yellow sensitizer of the present invention.
- the top picture is a tissue section not stained using the sensitizer, and the bottom picture is of a tissue section wherein the recipe included in addition the step of using the sensitizer.
- a “special stain” as defined herein is any chemically-based stain useful for histological analysis that is not an immunohistochemical stain, or an in situ hybridization stain.
- a representative listing of such stains may be found in “Theory and Practice of Histological Techniques,” Bancroft, John D., Stevens, Alan, eds., Fourth Ed. ( 1996 ), Churchill Livingstone Press, New York.
- the invention is directed to a method for enhancing the staining of tissue or features of interest therein by applying an effective amount of a bile salt in combination with a special stain to a tissue suspected of harboring a microorganism or other featue of diagnostic interest.
- the particular invention herein is directed to detecting H. pylori, the microorganism responsible for gastrointestinal ulcers.
- the method is practiced according to the following general recipe, all of which are carried out at room temperature:
- the invention described herein is called “Alcian Yellow Sensitizer” and comprises 1.9% sodium borate decahydrate and 0.5% sodium desoxycholate, in aqueous solution (DI water).
- the preferred range of concentration for the sodium desoxycholate is 0.32% to about 0.64%.
- 1 N NaOH is added to balance pH to between 9.25 and 9.35. All of the following are available from Ventana Medical Systems, Arlington, Ariz.: Alcian Yellow Toluidine Blue, P/N 10551. Alcian Yellow Stain, P/N 10549. Alcian Yellow Oxidizer, P/N 10514. Alcian Yellow Clarifier, P/N 10012. Rinse and volume adjust solutions are stock solutions, also available from Ventana.
- FIG. 1 includes two color pictures of a section of tissue on a slide stained using the recipe and Alcian Yellow sensitizer of the present invention.
- the top picture is a tissue section stained without using the sensitizer, and the bottom picture is of a tissue section wherein the recipe included in addition the step of using the sensitizer.
- the arrows point to areas where H. pylori are present.
- the bottom picture shows a remarkable enhancement of staining in the small blue dots, which is the H. pylori microorganism.
Abstract
The invention is directed to a method and composition of matter for enhancing the staining of tissue or features of interest therein by applying an effective amount of a bile salt in combination with a special stain to a tissue suspected of harboring a microorganism or other feature of diagnostic interest. The particular invention herein is directed to detecting H. pylori, the microorganism responsible for gastrointestinal ulcers. The composition of matter is a sensitizer for Alcian Yellow stain.
Description
- 1. Field of the Invention
- This invention is in the general field of histology, in particular the invention is an improved composition and method for staining microorganisms.
- 2. Description of Related Art
- Histology is the practice of examination and classification of tissue to aid in diagnosis of a disease or condition expressed in the morphology of the affected tissue. The practice of staining tissue or features of tissues with a visualizing agent to visualize or detect them, and thus provide a scientific basis for diagnosing a patient, is a very old art, going back over one hundred years. Histology can be divided into three basic practice areas: immunohistochemistry (use of antibodies to visualize tissue structures), in situ hybridization (use of DNA/RNA probes to detect) or special stains (chemical staining of tissue). Special stains is the term given to a collection of chemically-based stains that have been developed in response to difficult to stain tissue types, unusual diseases, infectious diseases or other non-typical situations affecting the tissue.
- The staining of histologic sections of tissue for the identification of H. pylori using a combination of Alcian Yellow and Toluidine Blue was published by Leung et al. (Leung, J K, Gibbob, K J, Vartanian, R K, “Rapid staining method for Heliobacter pylori in gastric biopsies,” J. Histol. 19:131-132 (1996).
- The invention is directed to a method and composition of matter for enhancing the staining of tissue or features of interest therein by applying an effective amount of a bile salt in combination with a special stain to a tissue suspected of harboring a microorganism or other feature of diagnostic interest. The particular invention herein is directed to detecting H. pylori, the microorganism responsible for gastrointestinal ulcers.
- The composition of matter is a sensitizer for Alcian Yellow stain.
- FIG. 1 includes two color pictures of a section of tissue on a slide stained using the recipe and Alcian Yellow sensitizer of the present invention. The top picture is a tissue section not stained using the sensitizer, and the bottom picture is of a tissue section wherein the recipe included in addition the step of using the sensitizer.
- The staining of histologic sections for the identification of Heliobactor pylori using a combination of Alcian Yellow and Toluidine Blue was published by Leung et al (Leung, J K, Gibbon, K J , Vartanian, R K: Rapid staining method for Heliobacter pylori in gastric biopsies. J. Histol 19:131-132, 1996). The combination normally results in H. pylori being stained blue, the mucin yellow and the background blue. We were able to replicate the results of this procedure using manual methods, but were unable to achieve good staining of the H. pylori organisms when the procedure was automated on the NexES® Special Stains instrument (Ventana Medical Systems, Inc., Tucson, Ariz.).
- To achieve a stable Toluidine stain solution, the published formulation was modified. Instead of adding a dilute solution of sodium hydroxide to the diluted Toluidine Blue stock solution just prior to use, we dispensed a solution of 0.025 M sodium borate, pH 9.30+/−0.05 to the tissue on the slide, followed by dispensing the Toluidine Blue dye. We used this same technique previously with Toluidine Blue solution applied as a counterstain in the automated AFB II Staining kit (Ventana Medical Systems, Tucson, Ariz.). In an analysis of this data, the inventors concluded that the nonionic detergent (Tween 20) used in the Water Wash solution interfered with binding of the Toluidine Blue dye to the microorganisms. We modified the borate buffer solution to add a series of compounds that we suspected might neutralize the effect of the nonionic detergent. Surprisingly, only one compound, sodium desoxycholate (Sigma-Aldrich, Cat. No. D6750), achieved the desired effect, and the effect was shown to be optimum at a SDC concentration between 0.32%- 0.64%. We chose the near midpoint concentration of 0.05% SDC for further experiments.
- The temperature of the NexES Special Stains instrument was reduced to ambient by leaving the heat turned off, and the concentration of Alcian Yellow and Toluidine dyes was optimized for the lower temperature (pp 16-23, AY notebook 3, attached). An experiment was then performed to test the optimized reagents against three (3) tissues cut at 3, 4 and 5 micron thicknesses. The optimized reagent performed satisfactorily in comparison to manual stains.
- A “special stain” as defined herein is any chemically-based stain useful for histological analysis that is not an immunohistochemical stain, or an in situ hybridization stain. A representative listing of such stains may be found in “Theory and Practice of Histological Techniques,” Bancroft, John D., Stevens, Alan, eds., Fourth Ed. ( 1996), Churchill Livingstone Press, New York.
- The invention is directed to a method for enhancing the staining of tissue or features of interest therein by applying an effective amount of a bile salt in combination with a special stain to a tissue suspected of harboring a microorganism or other featue of diagnostic interest. The particular invention herein is directed to detecting H. pylori, the microorganism responsible for gastrointestinal ulcers. On the NexES Special Stains instrument, the method is practiced according to the following general recipe, all of which are carried out at room temperature:
- 1) The slide with tissue adhered to it was rinsed using a solution of Tween 20.
- 2) 200 uL of Alcian Yello Oxidizer was added to the slide, and it was incubated for four minutes.
- 3) Liquid Coverslip™ (“LCS”) was applied.
- 4) Rinsed slide.
- 5) Adjusted slide volume and applied LCS.
- 6) Incubated for 4 more minutes.
- 7) Rinsed.
- 8) Applied Volume Adjust, and then 200 uL Alcian Yellow Clarifier.
- 9) Incubated for eight minutes, and the applied LCS.
- 10) Rinsed.
- 11) Adjusted slide volume, applied LCS
- 12) Incubated four minutes.
- 13) Rinsed slide.
- 14) Applied volume adjust, then added 200 uL of Alcian Yellow Stain.
- 15) Incubated four minutes, applied LCS.
- 16) Rinsed.
- 17) Volume adjusted, and added 200 uL Alcian Yellow Sensitizer.
- 18) Incubated four minutes, applied LCS.
- 19) Volume adjusted, and then added 200 uL Alcian Yellow Toluidine Blue.
- 20) Incubated four minutes, blowoff.
- 21) Rinsed.
- The invention described herein is called “Alcian Yellow Sensitizer” and comprises 1.9% sodium borate decahydrate and 0.5% sodium desoxycholate, in aqueous solution (DI water). The preferred range of concentration for the sodium desoxycholate is 0.32% to about 0.64%. 1 N NaOH is added to balance pH to between 9.25 and 9.35. All of the following are available from Ventana Medical Systems, Tucson, Ariz.: Alcian Yellow Toluidine Blue, P/N 10551. Alcian Yellow Stain, P/N 10549. Alcian Yellow Oxidizer, P/N 10514. Alcian Yellow Clarifier, P/N 10012. Rinse and volume adjust solutions are stock solutions, also available from Ventana.
- Results are best seen in relation to FIG. 1. FIG. 1 includes two color pictures of a section of tissue on a slide stained using the recipe and Alcian Yellow sensitizer of the present invention. The top picture is a tissue section stained without using the sensitizer, and the bottom picture is of a tissue section wherein the recipe included in addition the step of using the sensitizer. The arrows point to areas where H. pylori are present. The bottom picture shows a remarkable enhancement of staining in the small blue dots, which is the H. pylori microorganism.
Claims (10)
1. A method of enhancing the staining of tissue or features of diagnostic interest therein by applying an effective amount of a bile salt in combination with a special stain to a tissue suspected of harboring a microorganism or other feature of diagnostic interest.
2. The method of claim 1 wherein said bile salt is sodium desoxycholate.
3. The method of claim 1 wherein said special stain is Alcian Yellow.
4. The method of claim 1 wherein said microorganism is H. pylori.
5. A composition of matter comprising a bile salt in combination with a special stain.
6. The composition of claim 5 wherein said bile salt is sodium desoxycholate.
7. The composition of claim 5 wherein said special stain is Alcian Yellow
8. The composition of claim 6 wherein said sodium desoxycholate has at least a concentration of 0.32%.
9. The composition of claim 6 wherein said sodium desoxycholate has at most a concentration of 0.64%.
10. The composition of claim 6 wherein additionally present is sodium borate decahydrate.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/134,575 US20030003537A1 (en) | 2001-04-30 | 2002-04-29 | Method and composition of matter for enhancing staining of microorganisms |
| US11/172,057 US7300748B2 (en) | 2001-04-30 | 2005-06-29 | Method for enhancing staining of microorganisms |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28767901P | 2001-04-30 | 2001-04-30 | |
| US10/134,575 US20030003537A1 (en) | 2001-04-30 | 2002-04-29 | Method and composition of matter for enhancing staining of microorganisms |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US11/172,057 Division US7300748B2 (en) | 2001-04-30 | 2005-06-29 | Method for enhancing staining of microorganisms |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US20030003537A1 true US20030003537A1 (en) | 2003-01-02 |
Family
ID=23103893
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US10/134,575 Abandoned US20030003537A1 (en) | 2001-04-30 | 2002-04-29 | Method and composition of matter for enhancing staining of microorganisms |
| US11/172,057 Expired - Lifetime US7300748B2 (en) | 2001-04-30 | 2005-06-29 | Method for enhancing staining of microorganisms |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US11/172,057 Expired - Lifetime US7300748B2 (en) | 2001-04-30 | 2005-06-29 | Method for enhancing staining of microorganisms |
Country Status (2)
| Country | Link |
|---|---|
| US (2) | US20030003537A1 (en) |
| WO (1) | WO2002088670A1 (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040266015A1 (en) * | 2002-12-20 | 2004-12-30 | Dakocytomation Denmark A/S | Automated sample processing apparatus and a method of automated treating of samples and use of such apparatus |
| US20080305497A1 (en) * | 2007-05-23 | 2008-12-11 | Ventana Medical Systems, Inc. | Polymeric carriers for immunohistochemistry and in situ hybridization |
| US7695929B2 (en) | 2006-11-01 | 2010-04-13 | Ventana Medical Systems, Inc. | Haptens, hapten conjugates, compositions thereof and method for their preparation and use |
| US8703490B2 (en) | 2008-06-05 | 2014-04-22 | Ventana Medical Systems, Inc. | Compositions comprising nanomaterials and method for using such compositions for histochemical processes |
| RU2647474C1 (en) * | 2017-04-18 | 2018-03-15 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Курский государственный медицинский университет" Министерства здравоохранения Российской Федерации | Method of coloring and differentiation of microorganisms |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106442070B (en) * | 2016-11-30 | 2019-04-12 | 湖南农业大学 | A kind of production method of plant leaf blade slice |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5853748A (en) * | 1994-08-31 | 1998-12-29 | Cortecs (Uk) Limited | Pharmaceutical compositions |
| US20010050810A1 (en) * | 1997-09-04 | 2001-12-13 | Lorincz Andrew E. | Microscope slide having culture media and method for use |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0777743B1 (en) * | 1994-08-18 | 2000-08-23 | Minnesota Mining And Manufacturing Company | Culture medium for rapid count of coliform bacteria |
-
2002
- 2002-04-29 WO PCT/US2002/013455 patent/WO2002088670A1/en not_active Application Discontinuation
- 2002-04-29 US US10/134,575 patent/US20030003537A1/en not_active Abandoned
-
2005
- 2005-06-29 US US11/172,057 patent/US7300748B2/en not_active Expired - Lifetime
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5853748A (en) * | 1994-08-31 | 1998-12-29 | Cortecs (Uk) Limited | Pharmaceutical compositions |
| US20010050810A1 (en) * | 1997-09-04 | 2001-12-13 | Lorincz Andrew E. | Microscope slide having culture media and method for use |
Cited By (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7937228B2 (en) | 2002-12-20 | 2011-05-03 | Dako Denmark A/S | Information notification sample processing system and methods of biological slide processing |
| US20060045806A1 (en) * | 2002-12-20 | 2006-03-02 | Dakocytomation Denmark A/S | Apparatus for automated processing biological samples |
| US7960178B2 (en) | 2002-12-20 | 2011-06-14 | Dako Denmark A/S | Enhanced scheduling sample processing system and methods of biological slide processing |
| US20110167930A1 (en) * | 2002-12-20 | 2011-07-14 | Gordon Feingold | Information notification sample processing system and methods of biological slide processing |
| US20060088940A1 (en) * | 2002-12-20 | 2006-04-27 | Dakocytomation Denmark A/S | Isolated communication sample processing system and methods of biological slide processing |
| US20080241876A1 (en) * | 2002-12-20 | 2008-10-02 | Dako Denmark A/S | Information notification sample processing system and methods of biological slide processing |
| US10156580B2 (en) | 2002-12-20 | 2018-12-18 | Dako Denmark A/S | Information notification sample processing system and methods of biological slide processing |
| US7648678B2 (en) | 2002-12-20 | 2010-01-19 | Dako Denmark A/S | Method and system for pretreatment of tissue slides |
| US9778273B2 (en) | 2002-12-20 | 2017-10-03 | Dako Denmark A/S | Isolated communication sample processing system and methods of biological slide processing |
| US7758809B2 (en) | 2002-12-20 | 2010-07-20 | Dako Cytomation Denmark A/S | Method and system for pretreatment of tissue slides |
| US20040266015A1 (en) * | 2002-12-20 | 2004-12-30 | Dakocytomation Denmark A/S | Automated sample processing apparatus and a method of automated treating of samples and use of such apparatus |
| US9599630B2 (en) | 2002-12-20 | 2017-03-21 | Dako Denmark A/S | Method and apparatus for automatic staining of tissue samples |
| US8663978B2 (en) | 2002-12-20 | 2014-03-04 | Dako Denmark A/S | Method and apparatus for automatic staining of tissue samples |
| US20060046298A1 (en) * | 2002-12-20 | 2006-03-02 | Dako-Cytomation Denmark A/S | Enhanced scheduling sample processing system and methods of biological slide processing |
| US20060063265A1 (en) * | 2002-12-20 | 2006-03-23 | Dakocytomation Denmark A/S | Advance programmed sample processing system and methods of biological slide processing |
| US9229016B2 (en) | 2002-12-20 | 2016-01-05 | Dako Denmark A/S | Information notification sample processing system and methods of biological slide processing |
| US8216512B2 (en) | 2002-12-20 | 2012-07-10 | Dako Denmark A/S | Apparatus for automated processing biological samples |
| US8257968B2 (en) | 2002-12-20 | 2012-09-04 | Dako Denmark A/S | Method and apparatus for automatic staining of tissue samples |
| US8298815B2 (en) | 2002-12-20 | 2012-10-30 | Dako Denmark A/S | Systems and methods of sample processing and temperature control |
| US8386195B2 (en) | 2002-12-20 | 2013-02-26 | Dako Denmark A/S | Information notification sample processing system and methods of biological slide processing |
| US8394635B2 (en) | 2002-12-20 | 2013-03-12 | Dako Denmark A/S | Enhanced scheduling sample processing system and methods of biological slide processing |
| US8969086B2 (en) | 2002-12-20 | 2015-03-03 | Dako Denmark A/S | Enhanced scheduling sample processing system and methods of biological slide processing |
| US8788217B2 (en) | 2002-12-20 | 2014-07-22 | Dako Denmark A/S | Information notification sample processing system and methods of biological slide processing |
| US8529836B2 (en) | 2002-12-20 | 2013-09-10 | Dako Denmark A/S | Apparatus for automated processing biological samples |
| US8784735B2 (en) | 2002-12-20 | 2014-07-22 | Dako Denmark A/S | Apparatus for automated processing biological samples |
| US8673642B2 (en) | 2002-12-20 | 2014-03-18 | Dako Denmark A/S | Enhanced scheduling sample processing system and methods of biological slide processing |
| US20100184087A1 (en) * | 2006-11-01 | 2010-07-22 | Ventana Medical Systems, Inc. | Haptens, hapten conjugates, compositions thereof and method for their preparation and use |
| US20100297725A1 (en) * | 2006-11-01 | 2010-11-25 | Ventana Medical Systems, Inc. | Haptens, hapten conjugates, compositions thereof and method for their preparation and use |
| US8618265B2 (en) | 2006-11-01 | 2013-12-31 | Ventana Medical Systems, Inc. | Haptens, hapten conjugates, compositions thereof and method for their preparation and use |
| US7695929B2 (en) | 2006-11-01 | 2010-04-13 | Ventana Medical Systems, Inc. | Haptens, hapten conjugates, compositions thereof and method for their preparation and use |
| US8846320B2 (en) | 2006-11-01 | 2014-09-30 | Ventana Medical Systems, Inc. | Haptens, hapten conjugates, compositions thereof and method for their preparation and use |
| US9719986B2 (en) | 2006-11-01 | 2017-08-01 | Ventana Medical Systems, Inc. | Haptens, hapten conjugates, compositions thereof preparation and method for their preparation and use |
| US9017954B2 (en) | 2007-05-23 | 2015-04-28 | Ventana Medical Systems, Inc. | Polymeric carriers for immunohistochemistry and in situ hybridization |
| US9103822B2 (en) | 2007-05-23 | 2015-08-11 | Ventana Medical Systems, Inc. | Polymeric carriers for immunohistochemistry and in situ hybridization |
| US7985557B2 (en) | 2007-05-23 | 2011-07-26 | Ventana Medical Systems, Inc. | Polymeric carriers for immunohistochemistry and in situ hybridization |
| US9575067B2 (en) | 2007-05-23 | 2017-02-21 | Ventana Medical Systems, Inc. | Polymeric carriers for immunohistochemistry and in situ hybridization |
| US8445191B2 (en) | 2007-05-23 | 2013-05-21 | Ventana Medical Systems, Inc. | Polymeric carriers for immunohistochemistry and in situ hybridization |
| US8486620B2 (en) | 2007-05-23 | 2013-07-16 | Ventana Medical Systems, Inc. | Polymeric carriers for immunohistochemistry and in situ hybridization |
| US20080305497A1 (en) * | 2007-05-23 | 2008-12-11 | Ventana Medical Systems, Inc. | Polymeric carriers for immunohistochemistry and in situ hybridization |
| US8703490B2 (en) | 2008-06-05 | 2014-04-22 | Ventana Medical Systems, Inc. | Compositions comprising nanomaterials and method for using such compositions for histochemical processes |
| US10718693B2 (en) | 2008-06-05 | 2020-07-21 | Ventana Medical Systems, Inc. | Compositions comprising nanomaterials and method for using such compositions for histochemical processes |
| RU2647474C1 (en) * | 2017-04-18 | 2018-03-15 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Курский государственный медицинский университет" Министерства здравоохранения Российской Федерации | Method of coloring and differentiation of microorganisms |
Also Published As
| Publication number | Publication date |
|---|---|
| US20050239148A1 (en) | 2005-10-27 |
| WO2002088670A1 (en) | 2002-11-07 |
| US7300748B2 (en) | 2007-11-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7300748B2 (en) | Method for enhancing staining of microorganisms | |
| Tejada et al. | A test for the practical evaluation of male fertility by acridine orange (AO) fluorescence | |
| Kim et al. | Comparative evaluation of the alkaline comet assay with the micronucleus test for genotoxicity monitoring using aquatic organisms | |
| EP1136563B1 (en) | Method of staining, and detecting and counting bacteria | |
| EP1203825B1 (en) | Method of staining, detecting and counting bacteria, and a diluent for bacterial stain | |
| US20130302852A1 (en) | Hematoxylin Staining Method | |
| EP1112479A1 (en) | Removal of embedding media from biological samples and cell conditioning on automated staining instruments | |
| JP2020523615A (en) | Process record slide for special dyeing | |
| EP2904374B1 (en) | Methods and kits for clarifying pigmented samples | |
| CA2295545C (en) | Composition and method for staining cellular dna | |
| US8658109B2 (en) | Use of a bis-maleic anhydride cross-linking agent for fixation of a cell or tissue sample | |
| US20050032129A1 (en) | Detection of antigen by immunohistochemical staining | |
| US20170299482A1 (en) | Counterstains for a biological sample | |
| US9366604B2 (en) | Cytological or histological binding composition and staining methods | |
| US5508175A (en) | Environmentally safe parasitology fixative and stain | |
| Blaies et al. | A simplified method for staining mast cells with astra blue | |
| CN111088320A (en) | α -L-fucosidase determination reagent | |
| Gan | Troubleshooting immunohistochemistry | |
| CN109596402B (en) | Reagent for cell esterase staining | |
| CN110121364A (en) | Peptide nucleic acid conjugate | |
| US20230408382A1 (en) | Methods and Systems for Removing a Histological Stain From a Sample | |
| Kiernan | Silver staining for spirochetes in tissues: Rationale, difficulties, and troubleshooting | |
| CN117433867A (en) | Fluorescent staining solution for vaginal microorganisms and method for detecting vaginal microorganisms | |
| Sundell et al. | Staining Methods to Distinguish between Fungi and Erythrocytes in Ancient Tissue Histology. | |
| Unger et al. | In Situ Hybridization: principles and applications |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AS | Assignment |
Owner name: VENTANA MEDICAL SYSTEMS, INC., ARIZONA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:FISCHER, TIMOTHY;SHERMAN, WALTER;REEL/FRAME:013293/0466;SIGNING DATES FROM 20020820 TO 20020828 |
|
| STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |